519 672 2121
519 672 2121
Toggle mobile menu
Book a Consultation
Close mobile menu

 A settlement has been approved in the Canadian Invokana Class Actions.

The claim period has now passed (August 14, 2023) and no further claims are being accepted.

The Claims Administrator is currently analyzing and processing the claims filed. A notice of decision will be sent to individuals that filed a claim once the claims analysis is complete.

Invokana (canagliflozin) is a prescription medication indicated to lower blood sugar in adults with type 2 diabetes. Invokana is also available in combination with metformin, under the brand name Invokamet.

According to various research studies and reports made by the FDA and Health Canada, Invokana may cause serious side effects and injuries, including:

  • Increased risk of lower limb amputations (toe, foot, and leg)

  • Diabetic ketoacidosis

  • Increased risk of acute renal failure

  • Acute kidney injuries

  • Death

In 2018, Siskinds LLP filed a proposed class action for people in Canada who have been prescribed and taken Invokana, Invokamet, and/or Invokamet XR. Siskinds LLP’s class action alleged that the defendants failed to adequately warn individuals that the use of Invokana increases the risk of serious injuries and complications. Siskinds’ Québec-based affiliate, Siskinds Desmeules, also filed a similar action on behalf of Québec residents.

In November 2021, a Canada-wide Settlement was reached to resolve litigation against Janssen Inc., Janssen Pharmaceuticals, Inc., Janssen Ortho LLC, Johnson & Johnson, and Johnson & Johnson Inc. The Settlement was approved by the Superior Court of Quebec, the Ontario Superior Court of Justice, and the Saskatchewan Court of King’s Bench.

Eligible claimants had until August 14th, 2023, to file a claim. You can get more information by visiting the settlement website invokanacanadasettlement.com or by contacting the claims administrator at 1.877.400.1211.

Developments

A Canada-wide settlement has been reached in class action litigation relating to the prescription drugs Invokana, Invokamet, and Invokamet XR. The Settlement Agreement can be consulted here: [english] [french*] *please note that this version is not an official translation

The Settlement was approved by the Superior Court of Quebec on November 23, 2022, by the Ontario Superior Court of Justice on September 30, 2022, and by the Saskatchewan Court of King’s Bench on February 13, 2023.

For more information, please consult the detailed notice to members [English], [French].

You can get more information by visiting the settlement website invokanacanadasettlement.com or by contacting the claims administrator at 1.877.400.1211 or [email protected].

Please refer to the definition of the group in your province, as your rights may be impacted. The Classes have been defined as follows:

all persons resident in Saskatchewan who were prescribed Invokana, Invokamet, and/or Invokamet XR in Canada at any time on or before June 15, 2022 (“Saskatchewan Class”);

all persons resident in Quebec who were prescribed Invokana, Invokamet, and/or Invokamet XR in Canada at any time on or before June 21, 2022 (“Quebec Class”);

all persons resident in Canada, with the exception of Saskatchewan Class Members and Quebec Class Members, who were prescribed Invokana, Invokamet, and/or Invokamet XR in Canada at any time on or before June 16, 2022 (“Ontario Class”); and

all persons who by virtue of a personal relationship to one or more of such persons described above have claims for common law or statutory damages.

The claim period ended on August 14, 2023.

For more information, contact the Claims Administrator by phone at 1.877.400.1211 or by email at [email protected].

FAQs

What is a class action?

A class action is a lawsuit that is brought by one or more persons on behalf of a larger group of people whose claims share common legal and/or factual issues. Class actions provide a cost-effective way for groups of people with common interests to pursue a legal claim.

Do I have to pay anything to participate in the class action?

Class action lawyers are usually paid on a contingency basis. This means that class counsel are only paid if successful. Class counsel are paid a percentage of any settlement or court award. Class counsel fees are subject to court approval.

Who is affected by the Invokana class action?

Please refer to the definition of the group in your province, as your rights may be impacted. The Classes have been defined as follows:

all persons resident in Saskatchewan who were prescribed Invokana, Invokamet, and/or Invokamet XR in Canada at any time on or before June 15, 2022 (“Saskatchewan Class”);

all persons resident in Quebec who were prescribed Invokana, Invokamet, and/or Invokamet XR in Canada at any time on or before June 21, 2022 (“Quebec Class”);

all persons resident in Canada, with the exception of Saskatchewan Class Members and Quebec Class Members, who were prescribed Invokana, Invokamet, and/or Invokamet XR in Canada at any time on or before June 16, 2022 (“Ontario Class”); and

all persons who by virtue of a personal relationship to one or more of such persons described above have claims for common law or statutory damages.

Can I join the class action?

There are no steps required to “join” the class action. Assuming you fall within the scope of the class definition, you are automatically included in the class action unless you “opt-out” (exclude yourself from the class action).

Can I opt-out of the class action?

No, the opt-out periods for the class actions have expired.

I still have a question. Who should I contact?

For more information, visit the Claims Administrator dedicated page invokanacanadasettlement.com. You can also contact the Claims Administrator by phone at 1.877.400.1211 or by email at [email protected].

Documents

Quebec proceedings

A Canada-wide settlement has been reached in class action litigation relating to the prescription drugs Invokana, Invokamet, and Invokamet XR. The Settlement Agreement can be consulted here: [english] [french*] *please note that this version is not an official translation

The Settlement was approved by the Superior Court of Quebec on November 23, 2022, by the Ontario Superior Court of Justice on September 30, 2022, and by the Saskatchewan Court of King’s Bench on February 13, 2023.

For more information, please consult the detailed notice to members [English], [French].

You can get more information by visiting the settlement website invokanacanadasettlement.com or by contacting the claims administrator at 1.877.400.1211 or [email protected].

Please refer to the definition of the group in your province, as your rights may be impacted. The Classes have been defined as follows:

all persons resident in Saskatchewan who were prescribed Invokana, Invokamet, and/or Invokamet XR in Canada at any time on or before June 15, 2022 (“Saskatchewan Class”);

all persons resident in Quebec who were prescribed Invokana, Invokamet, and/or Invokamet XR in Canada at any time on or before June 21, 2022 (“Quebec Class”);

all persons resident in Canada, with the exception of Saskatchewan Class Members and Quebec Class Members, who were prescribed Invokana, Invokamet, and/or Invokamet XR in Canada at any time on or before June 16, 2022 (“Ontario Class”); and

all persons who by virtue of a personal relationship to one or more of such persons described above have claims for common law or statutory damages.

The claim period ended on August 14, 2023.

For more information, contact the Claims Administrator by phone at 1.877.400.1211 or by email at [email protected].

What is a class action?

A class action is a lawsuit that is brought by one or more persons on behalf of a larger group of people whose claims share common legal and/or factual issues. Class actions provide a cost-effective way for groups of people with common interests to pursue a legal claim.

Do I have to pay anything to participate in the class action?

Class action lawyers are usually paid on a contingency basis. This means that class counsel are only paid if successful. Class counsel are paid a percentage of any settlement or court award. Class counsel fees are subject to court approval.

Who is affected by the Invokana class action?

Please refer to the definition of the group in your province, as your rights may be impacted. The Classes have been defined as follows:

all persons resident in Saskatchewan who were prescribed Invokana, Invokamet, and/or Invokamet XR in Canada at any time on or before June 15, 2022 (“Saskatchewan Class”);

all persons resident in Quebec who were prescribed Invokana, Invokamet, and/or Invokamet XR in Canada at any time on or before June 21, 2022 (“Quebec Class”);

all persons resident in Canada, with the exception of Saskatchewan Class Members and Quebec Class Members, who were prescribed Invokana, Invokamet, and/or Invokamet XR in Canada at any time on or before June 16, 2022 (“Ontario Class”); and

all persons who by virtue of a personal relationship to one or more of such persons described above have claims for common law or statutory damages.

Can I join the class action?

There are no steps required to “join” the class action. Assuming you fall within the scope of the class definition, you are automatically included in the class action unless you “opt-out” (exclude yourself from the class action).

Can I opt-out of the class action?

No, the opt-out periods for the class actions have expired.

I still have a question. Who should I contact?

For more information, visit the Claims Administrator dedicated page invokanacanadasettlement.com. You can also contact the Claims Administrator by phone at 1.877.400.1211 or by email at [email protected].

Quebec proceedings